Natural killer cell signaling pathways - PubMed (original) (raw)
. 2004 Nov 26;306(5701):1517-9.
doi: 10.1126/science.1103478.
Affiliations
- PMID: 15567854
- DOI: 10.1126/science.1103478
Natural killer cell signaling pathways
Eric Vivier et al. Science. 2004.
Abstract
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in the early defenses against foreign cells, as well as autologous cells undergoing various forms of stress, such as microbial infection or tumor transformation. NK cell activation is controlled by a dynamic balance between complementary and antagonistic pathways that are initiated upon interaction with potential target cells. NK cells express an array of activating cell surface receptors that can trigger cytolytic programs, as well as cytokine or chemokine secretion. Some of these activating cell surface receptors initiate protein tyrosine kinase (PTK)-dependent pathways through noncovalent associations with transmembrane signaling adaptors that harbor intracytoplasmic ITAMs (immunoreceptor tyrosine-based activation motifs). Additional cell surface receptors that are not directly coupled to ITAMs also participate in NK cell activation. These include NKG2D, which is noncovalently associated to the DAP10 transmembrane signaling adaptor, as well as integrins and cytokine receptors. NK cells also express cell surface inhibitory receptors that antagonize activating pathways through protein tyrosine phosphatases (PTPs). These inhibitory cell surface receptors are characterized by intracytoplasmic ITIMs (immunoreceptor tyrosine-based inhibition motifs). The tyrosine-phosphorylation status of several signaling components that are substrates for both PTKs and PTPs is thus key to the propagation of the NK cell effector pathways. Understanding the integration of these multiple signals is central to the understanding and manipulation of NK cell effector signaling pathways.
Similar articles
- Natural killer cell receptor signaling pathway.
Vély F, Vivier E. Vély F, et al. Sci STKE. 2005 Jul 12;2005(292):cm6. doi: 10.1126/stke.2922005cm6. Sci STKE. 2005. PMID: 16014603 - Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P. André P, et al. Eur J Immunol. 2004 Apr;34(4):961-71. doi: 10.1002/eji.200324705. Eur J Immunol. 2004. PMID: 15048706 - Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
McVicar DW, Burshtyn DN. McVicar DW, et al. Sci STKE. 2001 Mar 27;2001(75):re1. doi: 10.1126/stke.2001.75.re1. Sci STKE. 2001. PMID: 11752646 Review. - NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
Horng T, Bezbradica JS, Medzhitov R. Horng T, et al. Nat Immunol. 2007 Dec;8(12):1345-52. doi: 10.1038/ni1524. Epub 2007 Oct 21. Nat Immunol. 2007. PMID: 17952078 - Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
Tassi I, Klesney-Tait J, Colonna M. Tassi I, et al. Immunol Rev. 2006 Dec;214:92-105. doi: 10.1111/j.1600-065X.2006.00463.x. Immunol Rev. 2006. PMID: 17100878 Review.
Cited by
- Natural killer cell engagers: From bi-specific to tri-specific and tetra-specific engagers for enhanced cancer immunotherapy.
Zhu A, Bai Y, Nan Y, Ju D. Zhu A, et al. Clin Transl Med. 2024 Nov;14(11):e70046. doi: 10.1002/ctm2.70046. Clin Transl Med. 2024. PMID: 39472273 Free PMC article. Review. - 127aa encoded by circSpdyA promotes FA synthesis and NK cell repression in breast cancers.
Gao X, Sun Z, Liu X, Luo J, Liang X, Wang H, Zhou J, Yang C, Wang T, Li J. Gao X, et al. Cell Death Differ. 2024 Oct 14. doi: 10.1038/s41418-024-01396-1. Online ahead of print. Cell Death Differ. 2024. PMID: 39402211 - Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives.
Rados M, Landegger A, Schmutzler L, Rabidou K, Taschner-Mandl S, Fetahu IS. Rados M, et al. Cancer Metastasis Rev. 2024 Dec;43(4):1401-1417. doi: 10.1007/s10555-024-10212-8. Epub 2024 Sep 18. Cancer Metastasis Rev. 2024. PMID: 39294470 Free PMC article. Review. - MDM2 inhibitors in cancer immunotherapy: Current status and perspective.
Zeng Q, Zeng S, Dai X, Ding Y, Huang C, Ruan R, Xiong J, Tang X, Deng J. Zeng Q, et al. Genes Dis. 2024 Mar 28;11(6):101279. doi: 10.1016/j.gendis.2024.101279. eCollection 2024 Nov. Genes Dis. 2024. PMID: 39263534 Free PMC article. Review. - The Multifaceted Roles of NK Cells in the Context of Murine Cytomegalovirus and Lymphocytic Choriomeningitis Virus Infections.
Hamdan TA. Hamdan TA. Immune Netw. 2024 Jun 27;24(4):e29. doi: 10.4110/in.2024.24.e29. eCollection 2024 Aug. Immune Netw. 2024. PMID: 39246620 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials